Subsensitivity to mitochondrial diazepam binding inhibitor receptor agonist FGIN-1-27-induced antiseizure effect in diazepam-withdrawn mice

Life Sciences

Volumn 62, Issue 14, 1998, Pages PL213-PL217

  Tsuda, Makoto ^a   Suzuki, Tsutomu ^a   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Antiseizure effect; Diazepam withdrawal; FGIN 1 27; Mitochondrial diazepam binding inhibitor receptor; Mouse

Indexed keywords

DIAZEPAM; DIAZEPAM BINDING INHIBITOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; N,N DI N HEXYL 2 (4 FLUOROPHENYL)INDOLE 3 ACETAMIDE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SEIZURE;

ANIMALIA;

EID: 0032570941     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00060-5     Document Type: Article

References (26)

1. 1. M.D. MAJEWSKA, N.L. HARRISON, R.D. SCHUWARTZ, J.L. BARKER and S.M. PAUL, Science 232 1004-1007 (1986).
2. 2. N.L. HARRISON, M.D. MAJEWSKA, J.W. HARRINGTON and J.L. BARKER, J. Pharmacol. Exp. Ther. 241 346-352 (1987).
3. 3. S.M. PAUL and R.H. PURDY, FASEB J. 6 2311-2322 (1992).
4. 4. J.J. LAMBERT, D. BELELLI, C. HILL-VENNING and J.A. PETER, Trends Pharmacol. Sci. 16 295-303 (1995).
5. 5. W.M. MOK, S. HERSCHKOWITZ and N.R. KRIEGER, J. Neurochem. 57 1296-1301 (1991).
6. 6. J.N. CRAWLEY, J.R. GLOWA, M.D. MAJEWSKA and S.M. PAUL, Brain Res. 398 382-385 (1986).
7. 7. S. WIELAND, N.C. LAN, S. MIRASEDEGHI and K.W. GEE, Brain Res. 565 263-268 (1991)
8. 8. D. BELELLI, M.B. BOLGER and K.W. GEE, Eur. J. Pharmacol. 166 325-329 (1989).
9. 9. A. CONCAS, M.C. MOSTALLINO, C. PERRA, R. LENER, G. ROSCETTI, M.L. BARBACCIA, R.H. PURDY and G. BIGGIO, Br. J. Pharmacol. 118 839-846 (1996)
10. 10. R.H. PURDY, A.L. MORROW, P.H. MOORE, Jr. and S.M. PAUL, Proc. Natl. Acad. Sci. U.S.A. 88 4553-4557 (1991).
11. 11. D.S. REDDY and S.K. KULKARNI, Psychopharmacology 128 280-292 (1996).
12. 12. M.J. BESMAN, K. YANAGIHASHI, T.D. LEE, M. KAWAMURA, P.F. HALL and J.E. SHIVELY, Proc. Natl. Acad. Sci. U.S.A. 86 4897-4901 (1989).
13. 13. A.G. MUKHIN, V. PAPADOPOULOS, E. COSTA and K.E. KRUEGER, Proc. Natl. Acad. Sci. U.S.A. 86 9813-9816 (1989).
14. 14. V. PAPADOPOULOS, P. GUARNERI, K.E. KRUEGER, A. GUIDOTTI and E. COSTA, Proc. Natl. Acad. Sci. U.S.A. 89 5113-5117 (1992).
15. 15. K.E. KRUEGER and V. PAPADOPOULOS, Annu. Rev. Pharmacol. Toxicol. 32 211-237 (1992).
16. 16. E. ROMEO, J. AUTA, A.P. KOZIKOWSKI, V. PAPADOPOULOS, G. PUIA and A. GUIDOTTI, J. Pharmacol. Exp. Ther. 262 971-978 (1992).
17. 17. E. ROMEO, S. CAVALLARO, A. KORNEYAV, P. KOZIKOWSKI, D. MA, A. POLO, E. COSTA and A. GUIDOTTI, J. Pharmacol. Exp. Ther. 267 462-471 (1993).
18. 18. M. TSUDA, T. SUZUKI and M. MISAWA, Addiction Biology 2 455-460 (1997).
19. 19. M. TSUDA, T. SUZUKI and M. MISAWA, Eur. J. Pharmacol. 324 63-66 (1997).
20. 20. T.J. HALEY and W.G. McCORMIK, Br. J. Pharmacol. 12 12-15 (1957).
21. 21. M. FUNADA, T. SUZUKI, M. NARITA, M. MISAWA and H. NAGASE, Brain Res. 619 163-172 (1993).
22. 22. J. AUTA, E. ROMEO, A. KOZIKOWSKI, D. MA, E. COSTA and A. GOUIDOTTI, J. Pharmacol. Exp. Ther. 265 649-656 (1993).
23. 23. A. KORNEYEV, B.S. PAN, A. POLO, E. ROMEO, A. GUIDOTTI and E. COSTA, J. Neurochem. 61 1515-1524 (1993).
24. 24. E. ROMEO, D.L. CHENEY, I. ZIVKOVIC, A. GUIDOTTI and E. COSTA, J. Pharmacol. Exp. Ther. 270 89-96 (1994).
25. 25. S. YANAURA, E. TAGASHIRA and T. SUZUKI, Jpn. J. Pharmacol. 25 453-463 (1975)
26. 26. T.G. KOKATE, B.E. SVENSSON and M.A. ROGAWSKI, J. Pharmacol. Exp. Ther. 270 1223-1229 (1994).